| Literature DB >> 30861128 |
Starr Cameron1, Ariana Lopez1,2, Raisa Glabman1,3, Emily Abrams1, Shawn Johnson4, Cara Field4, Frances M D Gulland4, Paul S Buckmaster1,5.
Abstract
One in 26 people develop epilepsy and in these temporal lobe epilepsy (TLE) is common. Many patients display a pattern of neuron loss called hippocampal sclerosis. Seizures usually start in the hippocampus but underlying mechanisms remain unclear. One possibility is insufficient inhibition of dentate granule cells. Normally parvalbumin-immunoreactive (PV) interneurons strongly inhibit granule cells. Humans with TLE display loss of PV interneurons in the dentate gyrus but questions persist. To address this, we evaluated PV interneuron and bouton numbers in California sea lions (Zalophus californianus) that naturally develop TLE after exposure to domoic acid, a neurotoxin that enters the marine food chain during harmful algal blooms. Sclerotic hippocampi were identified by the loss of Nissl-stained hilar neurons. Stereological methods were used to estimate the number of granule cells and PV interneurons per dentate gyrus. Sclerotic hippocampi contained fewer granule cells, fewer PV interneurons, and fewer PV synaptic boutons, and the ratio of granule cells to PV interneurons was higher than in controls. To test whether fewer boutons was attributable to loss versus reduced immunoreactivity, expression of synaptotagmin-2 (syt2) was evaluated. Syt2 is also expressed in boutons of PV interneurons. Sclerotic hippocampi displayed proportional losses of syt2-immunoreactive boutons, PV boutons, and granule cells. There was no significant difference in the average numbers of PV- or syt2-positive boutons per granule cell between control and sclerotic hippocampi. These findings do not address functionality of surviving synapses but suggest reduced granule cell inhibition in TLE is not attributable to anatomical loss of PV boutons.Entities:
Keywords: RRID:AB_10000344; RRID:AB_10013783; dentate gyrus; granule cell; parvalbumin; sea lion; synaptic bouton; synaptotagmin-2; temporal lobe epilepsy
Mesh:
Substances:
Year: 2019 PMID: 30861128 PMCID: PMC6656599 DOI: 10.1002/cne.24680
Source DB: PubMed Journal: J Comp Neurol ISSN: 0021-9967 Impact factor: 3.215